An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 019781
Company: VIRTUS

Products on NDA 019781

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
PROMETRIUM	PROGESTERONE	100MG	CAPSULE;ORAL	Prescription	AB	Yes	No
PROMETRIUM	PROGESTERONE	200MG	CAPSULE;ORAL	Prescription	AB	Yes	Yes
PROMETRIUM	PROGESTERONE	300MG	CAPSULE;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 019781

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/14/1998	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/19781lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/19781ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/19781.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/15/2024	SUPPL-25	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019781s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/019781Orig1s025ltr.pdf
11/18/2020	SUPPL-22	Manufacturing (CMC)-Packaging	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019781Orig1s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/019781Orig1s022ltr.pdf
09/30/2014	SUPPL-20	Manufacturing (CMC)		Label is not available on this site.
08/13/2014	SUPPL-19	Manufacturing (CMC)		Label is not available on this site.
04/19/2013	SUPPL-18	Manufacturing (CMC)		Label is not available on this site.
11/01/2011	SUPPL-17	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019781s017,020843s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/019781s017,020843s011ltr.pdf
06/30/2009	SUPPL-13	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019781s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/019781s013,020843s010ltr.pdf
03/04/2004	SUPPL-8	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/19781slr008,20843slr008ltr.pdf
03/01/2002	SUPPL-7	Manufacturing (CMC)-Control		Label is not available on this site.
12/10/2004	SUPPL-6	Labeling		Label is not available on this site.
12/10/2004	SUPPL-5	Labeling		Label is not available on this site.
04/17/2000	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
04/17/2000	SUPPL-3	Manufacturing (CMC)		Label is not available on this site.
04/17/2000	SUPPL-2	Manufacturing (CMC)		Label is not available on this site.
10/15/1999	SUPPL-1	Manufacturing (CMC)-Control		Label is not available on this site.

Labels for NDA 019781

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/15/2024	SUPPL-25	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/019781s025lbl.pdf
11/18/2020	SUPPL-22	Manufacturing (CMC)-Packaging	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019781Orig1s022lbl.pdf
11/01/2011	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019781s017,020843s011lbl.pdf
06/30/2009	SUPPL-13	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019781s013lbl.pdf
05/14/1998	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/19781lbl.pdf

Therapeutic Equivalents for NDA 019781

PROMETRIUM

CAPSULE;ORAL; 100MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
PROGESTERONE	PROGESTERONE	100MG	CAPSULE;ORAL	Prescription	No	AB	207724	AMNEAL PHARMS NY
PROGESTERONE	PROGESTERONE	100MG	CAPSULE;ORAL	Prescription	No	AB	200900	BIONPHARMA
PROGESTERONE	PROGESTERONE	100MG	CAPSULE;ORAL	Prescription	No	AB	208801	DR REDDYS
PROGESTERONE	PROGESTERONE	100MG	CAPSULE;ORAL	Prescription	No	AB	211285	EUGIA PHARMA
PROGESTERONE	PROGESTERONE	100MG	CAPSULE;ORAL	Prescription	No	AB	200456	SOFGEN PHARMS
PROGESTERONE	PROGESTERONE	100MG	CAPSULE;ORAL	Prescription	No	AB	205229	XIROMED
PROMETRIUM	PROGESTERONE	100MG	CAPSULE;ORAL	Prescription	Yes	AB	019781	VIRTUS

CAPSULE;ORAL; 200MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
PROGESTERONE	PROGESTERONE	200MG	CAPSULE;ORAL	Prescription	No	AB	207724	AMNEAL PHARMS NY
PROGESTERONE	PROGESTERONE	200MG	CAPSULE;ORAL	Prescription	No	AB	200900	BIONPHARMA
PROGESTERONE	PROGESTERONE	200MG	CAPSULE;ORAL	Prescription	No	AB	208801	DR REDDYS
PROGESTERONE	PROGESTERONE	200MG	CAPSULE;ORAL	Prescription	No	AB	211285	EUGIA PHARMA
PROGESTERONE	PROGESTERONE	200MG	CAPSULE;ORAL	Prescription	No	AB	200456	SOFGEN PHARMS
PROGESTERONE	PROGESTERONE	200MG	CAPSULE;ORAL	Prescription	No	AB	205229	XIROMED
PROMETRIUM	PROGESTERONE	200MG	CAPSULE;ORAL	Prescription	Yes	AB	019781	VIRTUS

Top